Postes actifs de Franc Šašek
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KRKA, D. D. | Directeur/Membre du Conseil | 01/01/2009 | - |
| Independent Dir/Board Member | 01/01/2009 | - | |
| Directeur Technique/Scientifique/R&D | 01/01/1984 | - | |
KRKA Farmaceutici Milano SRL
 KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Franc Šašek
Statistiques
Internationale
| Slovénie | 2 |
| Italie | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KRKA, D. D. | Health Technology |
| Entreprise privées | 1 |
|---|---|
KRKA Farmaceutici Milano SRL
KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004. | Health Technology |
- Bourse
- Insiders
- Franc Šašek
- Expérience
